Sweeny Nicole — SEC Form 4 filings
SEC reporting owner CIK 1827505. 10 Form 4 filings on record with FilingPulse; latest filed 2026-06-30.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2025-08-25 to 2026-06-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 7 filings — 16,344 shares, $285,036 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 25.
- Largest priced transaction: sale of 3,975 shares @ $15.57 ($61,878) in KalVista Pharmaceuticals, Inc., filed 2026-02-24.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| KalVista Pharmaceuticals, Inc. (KALV) | Chief Commercial Officer | 9 | — | 7 legs · 16,344 sh · $285,036 | 24 |
| Monopar Therapeutics (MNPR) | Director | 1 | — | — | 1 |
Form 4 filings — Sweeny Nicole
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-30 | 4 | Monopar Therapeutics (MNPR) | Grant/award (A): 1,284 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Disposition to issuer (D): 59,291 @ $0 · Disposition to issuer (D): 100,000 (derivative) · Disposition to issuer (D): 40,000 (derivative) · Disposition to issuer (D): 68,750 (derivative) · Disposition to issuer (D): 93,750 (derivative) | EDGAR |
| 2026-05-27 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Option exercise (M): 5,000 · Sale (S): 1,489 @ $26.78 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2026-05-26 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Option exercise (M): 6,250 · Sale (S): 1,861 @ $26.78 · Option exercise (M): 6,250 (derivative) @ $0 | EDGAR |
| 2026-04-20 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Option exercise (M): 6,250 · Sale (S): 1,862 @ $20.22 · Option exercise (M): 6,250 (derivative) @ $0 | EDGAR |
| 2026-02-24 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Option exercise (M): 6,250 · Option exercise (M): 5,000 · Sale (S): 3,975 @ $15.57 · Option exercise (M): 6,250 (derivative) @ $0 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2026-01-21 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-12-04 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Option exercise (M): 6,250 · Option exercise (M): 5,000 · Sale (S): 3,813 @ $13.45 · Option exercise (M): 6,250 (derivative) @ $0 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2025-08-26 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Option exercise (M): 5,000 · Sale (S): 1,480 @ $13.42 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2025-08-25 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Option exercise (M): 6,250 · Sale (S): 1,864 @ $13.22 · Option exercise (M): 6,250 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1827505 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →